A retrospective analysis of moderate and severe COVID-19 pneumonia with special reference to the use of Adjuvant Tocilizumab

A retrospective analysis of moderate and severe COVID-19 pneumonia with special reference to the use of Adjuvant Tocilizumab

Background and Aim: Coronavirus disease 2019 (COVID-19) pneumonia is associated with a hyper-inflammatory syndrome which may cause life-threatening acute respiratory distress syndrome. The aim of this study was to evaluate the safety and efficacy of an anti-inflammatory agent, tocilizumab (TCZ), a m...

Full description

Bibliographic Details
Main Authors: Pratik Raval, Benny Jose Panakkal, Dinesh Joshi, Karthik Natrajan, Anand Shukla, Gajendra Dubey, Sibasis Sahoo, Subhendu Bajpai
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Archives of Medicine and Health Sciences
Subjects:
coronavirus disease 2019 pneumonia
interleukin 6
severe acute respiratory syndrome coronavirus 2
tocilizumab
Online Access:http://www.amhsjournal.org/article.asp?issn=2321-4848;year=2022;volume=10;issue=2;spage=176;epage=180;aulast=Raval

Internet

http://www.amhsjournal.org/article.asp?issn=2321-4848;year=2022;volume=10;issue=2;spage=176;epage=180;aulast=Raval

Similar Items